Wise, David R. http://orcid.org/0000-0003-3419-4723
Pachynski, Russell K.
Denmeade, Samuel R.
Aggarwal, Rahul R. http://orcid.org/0000-0001-7003-7982
Deng, Jiehui http://orcid.org/0000-0001-7986-8643
Febles, Victor Adorno http://orcid.org/0000-0003-4386-3490
Balar, Arjun V.
Economides, Minas P.
Loomis, Cynthia
Selvaraj, Shanmugapriya http://orcid.org/0000-0003-1718-0282
Haas, Michael
Kagey, Michael H.
Newman, Walter
Baum, Jason
Troxel, Andrea B.
Griglun, Sarah
Leis, Dayna
Yang, Nina
Aranchiy, Viktoriya
Machado, Sabrina
Waalkes, Erika
Gargano, Gabrielle
Soamchand, Nadia
Puranik, Amrutesh
Chattopadhyay, Pratip
Fedal, Ezeddin
Deng, Fang-Ming
Ren, Qinghu
Chiriboga, Luis
Melamed, Jonathan http://orcid.org/0000-0003-2844-7990
Sirard, Cynthia A. http://orcid.org/0000-0003-4856-4457
Wong, Kwok-Kin
Article History
Received: 31 July 2023
Revised: 16 January 2024
Accepted: 22 January 2024
First Online: 10 February 2024
Competing interests
: DRW is a paid consultant for Leap Therapeutics, Foundation Medicine, Pfizer, Janssen, Sanofi, Lilly, Labcorp, Myovant, Bayer, AstraZeneca, Accutar. He has received travel funding from Pfizer and Bayer.